Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti-Toll-Like Receptor-2 Antibody

F Arslan, M. B Smeets, L. A.J O'Neill, B Keogh, P McGuirk, L Timmers, C Tersteeg, I. E Hoefer, P. A Doevendans, G Pasterkamp and D. P.V. de Kleijn

Circulation 121 ( 1 ): 80 - 90 , 2010